Divi's Laboratories reports 17% rise in Q2 consolidated net profit

08 Nov 2021 Evaluate

Divi's Laboratories has reported results for second quarter ended September 30, 2021.

The company has reported a rise of 18.14% in its net profit at Rs 606.39 crore for the quarter under review as compared to Rs 513.30 crore for the same quarter in the previous year. Total income of the company increased by 15.03% at Rs 1,986.97 crore for Q2FY22 as compared Rs 1,727.42 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 16.72% in its net profit at Rs 606.46 crore for the quarter under review as compared to Rs 519.59 crore for the same quarter in the previous year. Total income of the company increased by 13.82% at Rs 2,006.62 crore for Q2FY22 as compared Rs 1,762.94 crore for the corresponding quarter previous year.

Divis Lab Share Price

5817.40 -45.60 (-0.78%)
09-Jan-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1827.00
Dr. Reddys Lab 1373.60
Cipla 1491.70
Lupin 2250.40
Zydus Lifesciences 1008.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.